dabigatran etexilate galenicum 110 mg hard capsules
galenicum health, s.l. calle sant gabriel, 50 08950 esplugues de llobregat (barcelona) , spain - dabigatran etexilate - hard capsule - dabigatran etexilate 110 mg - antithrombotic agents
dabigatran etexilate galenicum 150 mg hard capsules
galenicum health, s.l. calle sant gabriel, 50 08950 esplugues de llobregat (barcelona) , spain - dabigatran etexilate - hard capsule - dabigatran etexilate 150 mg - antithrombotic agents
dabigatran etexilate clonmel 110 mg hard capsules
clonmel healthcare ltd - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate
dabigatran etexilate clonmel 150 mg hard capsules
clonmel healthcare ltd - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate
dabigatran etexilate clonmel 75 mg hard capsules
clonmel healthcare ltd - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate
dabigatran etexilate krka 110 mg hard capsules
krka, d.d., novo mesto - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate
dabigatran etexilate krka 150 mg hard capsules
krka, d.d., novo mesto - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate
dabigatran etexilate krka 75 mg hard capsules
krka, d.d., novo mesto - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate
galliapharm 0.74 – 1.85 gbq radionuclide generator
eckert & ziegler radiopharma gmbh - germanium (68ge) chloride; gallium (68ga) chloride - radionuclide generator - 0.74-1.85 gigabecquerel(s) - other diagnostic radiopharmaceuticals
gallium ga-68 psma-11- gallium ga-68 gozetotide injection, solution
ucsf radiopharmaceutical facility - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozeotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide injection. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there ar